Stocks
Adaptive Biotechnologies (ADPT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 4.02 | 1.25 | 2.32 | 1.38 | 0.62 | 0.93 | |||
| Changes by years, y/y, % | -47% | -69% | +86% | -41% | -55% | -30.4% | |||
Adaptive Biotechnologies. Debt/EBITDA
Adaptive Biotechnologies. Debt/EBITDA, changes, %
Adaptive Biotechnologies (ADPT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.39 | 0.62 | 1.19 | 0.37 | 0.93 | 0.93 | ||
| Changes by years, y/y, % | -36% | -71% | -39% | -81% | -44% | |||
| Changes by quarters, q/q, % | -16% | -55% | +91% | -69% | +151% | |||
